rs72554323
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000531.6(OTC):c.179C>A(p.Ser60*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000531.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.179C>A | p.Ser60* | stop_gained | Exon 2 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.179C>A | p.Ser60* | stop_gained | Exon 4 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.179C>A | p.Ser60* | stop_gained | Exon 2 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
NM_000531.5(OTC):c.179C>A(S60*) is expected to be pathogenic in the context of ornithine transcarbamylase deficiency. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in OTC, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at